Upload
janghanbyul
View
228
Download
0
Embed Size (px)
Citation preview
8/10/2019 Specimen Collection and Processing
1/7
7/3/13
1
Maria Ruth B. Pineda, RMT, Ph.D.
Department of Medical Technology
University of Santo Tomas2
Objective and Scope
of Unit 4
Use standard protocol in handling and collecting specimen Promote ethical and social responsibilities in dealing with patients. Collaborate with other health care professionals for methods and protocols of specimen
handling and patient preparations needed for each determination. Communicate properly the laboratory procedures and requirements to patients and physicians.
1. Types of Specimen
1.1. Collection and Labeling
1.2. Handling, Transport processing, Storage, and Preservation
2. Specimen variables
2.1. Pre-collection
2.1.1. Patient identification and preparation2.1.2. Anticoagulants and preservatives
2.2. Collection
2.3. Post-collection
Types of Specimen
Body fluids: blood, CSF, urine, sweat, gastric juices, etc.
Tissues
Organs
Others: hair, nail, skin scrapings, etc.
3
TYPES OF BLOOD SPeCIMEN
1. Serum
! liquid portion of clotted blood
! clearer than plasma
! with albumin and globulin but no fibrinogen
! not lipemic nor icteric
2. Plasma
! Liquid portion of unclotted blood
! with fibrinogen
3. Whole Blood
! plasma and red cells
! with anticoagulant4
3 ways of obtaining
blood specimen
1. Venipuncture
!
purplish venous blood
2. Arterial Puncture
! bright red arterial blood
!
used for ABG test
3. Skin Puncture
!
usually contaminated with tissues juices
! method of choice for pediatric and geriatric patients,extremely obese adults, severe burn patients, and those
with thrombotic tendencies (bleeding disorders)
5
VEINS
Thinner walls than arteries
Collapse easily
Less pressure inside
6
8/10/2019 Specimen Collection and Processing
2/7
7/3/13
2
ARTERIES
Thick walls
Higher pressure: pulse
*no need to pull the plunger
7
CAPILLARIES
One cell thick to allow exchange of gases
For micromethod collection only
8
9
..
.
.
.
..
.
.
.
.
.
.
.
..
..
.
..
.
.
.
.
.
I I I
Tunica intima(endothelium)
Valve
Elastic tissue
Tunica media(smooth muscle)
Tunica adventitia(connective tissue)
Artery Vein
Capillary
Arteriole
Blood flow
Venule
FIGURE 2-1. Artery, vein, and capillary structure. (Reprinted with permission from McCall R, Tankersley C.
Phlebotomy essentials. 4th ed. Baltimore, Md.: Lippincott Williams & Wilkins, 2008.)
Venipuncture sites
1. Antecubital fossa
! Median cubital! Cephalic! basilic
2. Other veins
! Brachial! Femoral!
Radial
! Ankle veins
! Veins of the dorsalhand
!
Etc.10
11
,
. .
.
:
:.
,
, ,
.
:
. . ,
,
.
.
. ,:
Basilic vein
Ant. mediancutaneous nerve
Post. mediancutaneous nerve
Brachialartery
Cephalicvein
Cephalicvein
Accessorycephalic
vein
Median cubitalvein
Medial cubitalnerve
Subclavianvein
Basilic vein
Median vein
A
CephalicveinBasilic vein
Dorsalmetacarpal
veins
C
Brachial artery
Cephalic vein
Cephalic vein
Accessorycephalic vein
Mediancephalic vein
Basilic vein
Ant. mediancutaneousnerve
Post. mediancutaneousnerve
Medialcubitalnerve
Subclavianvein
Median basilicvein
Basilic vein
Median vein
B
.
.
.
. .
. . .: .
Inappropriate
venipuncture sites
Arm on side of mastectomy
Edematous areas
Hematomas
Arm in which blood is being transfused
Scarred area
Arms with fistulas or vascular grafts
Sites above an IV cannula
12
8/10/2019 Specimen Collection and Processing
3/7
7/3/13
3
Skin puncture sites
lateral or at the medial surface of the heel
ring finger
ear lobes
How to puncture?
Clean the area
One quick deep stab
Perpendicular to the finger prints
13
METHODS OF BLOOD
Collection based on amount
1.
Macromethod 1.0 mL and above
2. Micromethod 0.1 to 0.9 mL
3. Ultramicromethod 0.01 to 0.09 mL
4. Nanoliter method 0.001 to 0.009 mL
14
Evacuated tubes
Tube Color and Anticoagulant/Additive
Stopper color Anticoagulant/additive Specimen type/use Mechanism of action
Red (glass) None Serum/chemistry and serology N/A
Red (plastic/Hemogard) Clot activator Serum/chemi stry and serology Sil ica clot activator
Lavender (glass) K3EDTA in liquid form Whole blood/hematology Chelates (binds) calcium
Lavender (plastic) K2EDTA/spray-dried Whole blood/hematology Chelates (binds) calcium
Pink Spray-dried K2EDTA Whole blood/blood bank andmolecular diagnostics
Chelates (binds) calcium
White EDTA and gel Plasma/molecular diagnostics Chelates (binds) calcium
Light blue Sodium citrate Plasma/coagulation Chelates (binds) calcium
Light blue Thrombin and soybean trypsininhibitor
Plasma/coagulation Fi brin degradation products
Black Sodium citrate Plasma/sed rateshematology Chelates (binds) calcium
Light green/black Lithium heparin and gel Plasma/chemistry Inhibits thrombin formation
Green Sodium heparin, lithium heparin Plasma/chemistry Inhibits thrombin formation
Royal blue Sodium heparin, K2E DTA P las ma /ch emi str y/ to xi co log y He pa ri n i nh ib its th ro mb in fo rma ti on
Na2EDTA binds calcium
Gray Sodium fluoride/potassium oxalate Plasma/glucose testing Inhibits glycolysis
Yellow Sterile containing sodiumpolyanetholesulfonate
S er um /m ic ro biology c ul tu re A ids in bac te ri al r eco very by inh ib it ingcomplement, phagocytes, andcertain antibiotics
Yellow Acid citrate dextrose Plasma/blood bank, HLA phenotyping,and paternity testing
WBC preservative
Tan (glass) Sodium heparin Plasma/lead testing Inhibits thrombin formation
Tan (plastic) K2EDTA Plasma/lead testing Chelates (binds) calcium
Yellow/gray and orange Thrombin Serum/chemistry Clot activator
Red/gray and gold Clot activator separation gel Serum/chemistry Silica clot activator
3 .
..
.
.
I I I
.
3 . 3 .
.. .
.
. .. .
.. . .
..
.
.
.
.
.
.
.
.
.
..
.
. ..
.
..
.
.
..
.
..
..
..
15
EFFECT OF
INCORRECTANTICOAGULANT
++ ++
Additive Test Effect
EDTA Alkaline phosphatase InhibitsCreatine kinase InhibitsL eucine a mino pe pt idas e Inh ib it sCalcium and iron DecreasePT and PTT IncreaseSodiu m and p otassiu m IncreasePlatelet a ggregation Prevents
Oxalate Acid phosphatase InhibitsAlkaline phosphatase InhibitsAmylase InhibitsLD InhibitsCalcium DecreasesSodiu m and p otassiu m IncreaseCell morphology Distorts
Citrate ALT and AST InhibitAlkaline phosphatase InhibitsAcid phosphatase StimulatesAmylase DecreasesCalcium DecreasesSodiu m and p otassiu m IncreaseLabile coagulat ion factors P reserve
Heparin Triiodothyronine IncreasesThyroxine IncreasesPT and PTT Increase
Wrights stain Causes blue backgroundLith ium (L iHep tubes on ly) IncreasesSodium (NaHep tubes on ly) Increases
Fluorides Acid phosphatase DecreasesAlkaline phosphatase Decreases
Amylase DecreasesCreatine kinase Decreases
ALT and AST DecreaseCell morphology Distorts
.
16
PROPER ORDER OF DRAW
l l l ll ll
Order of Draw: Evacuated Tube and Syringe
1. Blood-culture tubes (yellow)
2. Coagulation sodium citrate tube (blue stopper)
3. Serum tubes with or without clot activator or gel separator
4. Heparin tubes with or without gel (green stopper)
5. Ethylenediaminetetraacetic acid tubes (lavender stopper)
6. Glycolytic inhibitor tubes (gray stopper)
17
Rationale of the
order of draw
18
TABLE 2-3 ORDER OF DRAW, STOPPER COLORS, AND RATIONALE FOR COLLECTION ORDER
O RD ER OF DR AW T UB E S TO PP ER CO LO R R AT IO NA LE FO R C OL LE CT IO N O RD ER
Blood cultures (ster ile Yel low SPS Minimizes chance of microbial contaminationcollections) Sterile media bottle
C oa gu lat io n t ub es L ig ht bl ue T he fi rst ad di ti ve tu be in th e o rd er bec au se al l o th er
additives affect coagulation tests
G las s n on ad di ti ve t ub es R ed P re ve nt s c on tam in at io n b y a dd it iv es i n o th er t ub es
P la st ic c lo t a ct ivat or t ubes Red F il le d a ft er c oa gu la ti on t es ts bec ause s il ic a par ti cl esSerum separator tubes Red and gray rubber activate clotting and affect coagulation tests (carry-over
(SSTs) Gold plastic of silica into subsequent tubes can be overridden byanticoagulant in them)
Plasma separator tubes Green and gray rubber Heparin affects coagulation tests and interferes in(PSTs) Lig ht-green plastic co llection of serum specimens; causes the leastHeparin tubes Green interference in tests other than coagulation tests
EDTA tubes Lavender Responsible for more carry-over problems than any otherPink additive: elevates Na and K levels, chelates and decreases
P lasma preparation Pearl top calcium and i ron levels, e levates PT and PTT results
tubes (PPTs) Sodium fluoride and potassium oxalate affectO xal ate /f lu or id e t ub es G ray s od iu m an d p ot as siu m l ev el s, res pe cti ve ly , a ft er hem at ol-
ogy tubes because oxalate damages cell membranes and
causes abnormal RBC morphology. Oxalate interferes inenzyme reactions.
. ,
. ,
., ,
.
, , , .
.,
, .
,,
.
, ,.
. .,
:
.
.
8/10/2019 Specimen Collection and Processing
4/7
7/3/13
4
Blood collection
procedure: open system1. Check request slip
2. Identify the patient
3. Verify diet restrictions/fasting
4. Put on gloves and assemble the equipment
5. Reassure and position the patient
6. Apply tourniquet
7. Select the venipuncture site
8. Cleanse the area
9. Inspect the needle and syringe19
Blood collection
procedure: open system
10.
Tie the tourniquet
11. Perform venipuncture
12. Remove tourniquet before pulling out the needle.
13. Apply cotton/bandage
14. Transfer blood collected to appropriate tubes (mix ifnicessary)
15. Label tubes
16. Dispose contaminated materials
17. Transport specimen immediately
20
Blood collection
procedure1. Check request slip
2. Identify the patient
3. Verify diet restrictions/fasting
4. Put on gloves and assemble the equipment
5. Reassure and position the patient
6. Apply tourniquet
7. Select the venipuncture site
8. Cleanse the area
9. Inspect the needle and syringe21
Blood collection
procedure10. Tie the tourniquet
11. Perform venipuncture
12. Fill the tubes and mix if necessary
13. Release the tourniquet before withdrawing theneedle
14. Apply bandage
15. Label tubes
16. Dispose contaminated materials
17. Transport specimen immediately22
Specimen Variables
Pre-analytical
Analytical
Post-analytical
i i i l l ll i . i l ll i
ll i l i . i i i
Technologist picksup tubes
RepeatY
Patient ID
Patient confirmation
Check request &patient preparation
yes
no
Politely explain why &give correct instructions
end
Prepare materials& collect blood
Forward bloodinside the lab
Label specimen
Inside
thelab
Receipt oflab. request
Meet patient prep
i i i l l ll i .i l ll i
ll i l i . i i i
Tubes sorted byrequirements/degree
of urgency
Technologist placesspecimens in thehematology racks
Racks carried to theanalyzers and
processed
Reports pulled anddata collated
Results reviewed
A
i i i l l ll i . i l ll i
ll i l i . i i i
Tubesplacedinpending analysis
racks
Specimensreanalyzed
Originalandrepeatedresults
filedtogether
NO
YES
Encode results& sign
Release results
end
Technologistplaces specimen
in CC racks
23
Pre-COLLECTION
Patient preparation
Patients request
Blood collection
Specimen Labeling
Entry to logbook
Specimen preparation
24
8/10/2019 Specimen Collection and Processing
5/7
8/10/2019 Specimen Collection and Processing
6/7
7/3/13
6
POSTURE
! leads to efflux ortransfer of filterablesubstances from the
intravascular space tothe interstitial
! increases TP, Bilirubin,Lipids, and enzymes
STRESS
! affect secretions ofadrenal hormones
! leads tohyperventilation
! disturbance of acid-base balance affecting ABG test
31
Diurnal rhythms
body fluids and analytes fluctuations during theday
,. ,
, ,, , , .
., , , .
, ,, .
, .
.. ,
, , ., .
. , ,, ,
. ,, , ,
, . , ,, , ,
. ,, , , , ,
,, . ,
. .
,, , , , .
, ,. ,
, . , ,,
. ,. ,
, , . ,.
., , .
, ,,
. , ,
. , ,.
, . ,, .
, , .
,
ll
.
.
.
.
.
.
.
.
. I
. : I
Tests Affected by Diurnal Variation, Posture, and Stress
Cortisol Peaks 46 AM; lowest 8 PM12 AM; 50% lower at8 PMthan at 8 AM; increased with stress
Adrenocorticotropichormone
Lower at night; increased with stress
Plasma renin activity Lower at night; higher standing than supine
Aldosterone Lower at night
Insulin Lower at night
Growth hormone Higher in afternoon and evening
Acid phosphatase Higher in afternoon and evening
Thyroxine Increases with exercise
P rola ct in Hi gh er wi th st re ss; hi ghe r l eve ls a t 4 a nd 8 AMand at 8 and 10 PM
Iron Peaks early to late morning; decreases up to30% during the day
Calcium 4% decrease supine
, ., ,
.
.
,.
., , , , ,
, , ..
., , ,
, , ,.
,
, ..
, ,
.
.: , , ,
, . , , ,.
., .
..
,
, , ., ,
, , .
. ..
.
.. ,
, , . ,
,, .
, ,, ,
., , , , , .
, .
32
Specimen collection
en Common Errors in Specimen Collection
1. Misidentification of patient
2. Mislabeling of specimen
3. Short draws/wrong anticoagulant/blood ratio
4. Mixing problems/clots
5. Wrong tubes/wrong anticoagulant
6. Hemolysis/lipemia
7. Hemoconcentration from prolonged tourniquet time
8. Exposure to light/extreme temperatures
9. Improperly timed specimens/delayed delivery to laboratory
10. Processing errors: Incomplete centrifugation, incorrect log-in, improper
storage
l l l
l
l
l
l l l
l l
l
33
Reasons for Specimen Rejection
Hemolysis/lipemia
Clots present in an anticoagulated specimen
Nonfasting specimen when test requires fasting
Improper blood collection tube
Short draws, wrong volume
Improper transport conditions (ice for blood gases)
Discrepancies between requisition and specimen label
Unlabeled or mislabeled specimen
Contaminated specimen/leaking container34
Specimen collection
Effect of hemolysis
.
.
.
.
.
.
.
.. . . . .
.
Changes in Serum Concentration (or Activities) of SelectedConstituents Due to Lysis of Erythrocytes (RBCs)
Constituent
Ratio ofconcentration (oractivity) in RBC toconcentration (or
activity) in serum
Percent change ofconcentration (oractivity) in serumafter lysis of 1%RBC, assuming a
hematocrit of 0.50Lactate dehydrogenase 16 : 1 +272.0
Aspartateaminotransferase
4 : 1 +220.0
Potassium 23 : 1 +24.4
Alanineaminotransferase
6.7 : 1 +55.0
Glucose 0.82 : 1 5.0
Inorganic phosphate 0.78 : 1 +9.1
Sodium 0.11 : 1 1.0
Calcium 0.10 : 1 +2.9
..
: . .. .
: .
Needle insertion
36
When a vein rolls, the needle mayslip to the side of the vein withoutpenetrating it
Correct insertion technique; bloodflows freely into needle
A
B
D
G
C
E
Bevel on vein lower wall does not
allow blood to flow
Needle partially inserted andcauses blood leakage into tissue
Bevel on vein upper wall does notallow blood to flow
Needle inserted too far
Collapsed
F
. . . . . .
. . . .
. .
8/10/2019 Specimen Collection and Processing
7/7